Thermo Fisher Scientific V. A. Graiciuno, Vilnius, Lithuania.
Microb Cell Fact. 2011 May 10;10:31. doi: 10.1186/1475-2859-10-31.
The eukaryotic RNase ribonuclease/angiogenin inhibitors (RI) are a protein group distinguished by a unique structure - they are composed of hydrophobic leucine-rich repeat motifs (LRR) and contain a high amount of reduced cysteine residues. The members of this group are difficult to produce in E. coli and other recombinant hosts due to their high aggregation tendency.
In this work dithiothreitol (DTT) was successfully applied for improving the yield of correctly folded ribonuclease/angiogenin inhibitor in E. coli K12 periplasmic and cytoplasmic compartments. The feasibility of the in vivo folding concepts for cytoplasmic and periplasmic production were demonstrated at batch and fed-batch cultivation modes in shake flasks and at the bioreactor scale.Firstly, the best secretion conditions of RI in the periplasmic space were evaluated by using a high throughput multifactorial screening approach of a vector library, directly with the Enbase fed-batch production mode in 96-well plates. Secondly, the effect of the redox environment was evaluated in isogenic dsbA+ and dsbA- strains at the various cultivation conditions with reducing agents in the cultivation medium. Despite the fusion to the signal peptide, highest activities were found in the cytoplasmic fraction. Thus by removing the signal peptide the positive effect of the reducing agent DTT was clearly proven also for the cytoplasmic compartment. Finally, optimal periplasmic and cytoplasmic RI fed-batch production processes involving externally added DTT were developed in shake flasks and scaled up to the bioreactor scale.
DTT highly improved both, periplasmic and cytoplasmic accumulation and activity of RI at low synthesis rate, i.e. in constructs harbouring weak recombinant synthesis rate stipulating genetic elements together with cultivation at low temperature. In a stirred bioreactor environment RI folding was strongly improved by repeated pulse addition of DTT at low aeration conditions.
真核核糖核酸酶/血管生成素抑制剂(RI)是一组具有独特结构的蛋白质,它们由疏水性亮氨酸丰富的重复基序(LRR)组成,并且含有大量还原半胱氨酸残基。由于其高聚集倾向,该组的成员在大肠杆菌和其他重组宿主中难以生产。
在这项工作中,二硫苏糖醇(DTT)成功地应用于提高正确折叠的核糖核酸酶/血管生成素抑制剂在大肠杆菌 K12 周质和细胞质隔间中的产量。在分批和补料分批培养模式下,在摇瓶和生物反应器规模上,对细胞质和周质生产的体内折叠概念的可行性进行了证明。首先,通过使用载体文库的高通量多因素筛选方法,直接在 96 孔板中使用 Enbase 补料分批生产模式,评估了 RI 在周质空间中的最佳分泌条件。其次,在不同的培养条件下,在含有还原剂的培养基中,在同基因 dsbA+和 dsbA-菌株中评估了氧化还原环境的影响。尽管与信号肽融合,但在细胞质部分中发现了最高的活性。因此,通过去除信号肽,还原剂 DTT 的积极作用也在细胞质隔间中得到了明显证明。最后,在摇瓶中开发了涉及外部添加 DTT 的最佳周质和细胞质 RI 补料分批生产工艺,并将其放大到生物反应器规模。
DTT 大大提高了 RI 在低合成率下的周质和细胞质积累和活性,即在含有弱重组合成率规定遗传元件的构建体中,并在低温下培养。在搅拌生物反应器环境中,通过在低通气条件下重复脉冲添加 DTT,强烈改善了 RI 的折叠。